Uroalerts Men's Health Weekly

August 12, 2024

Videos

Peer-to-Peer Clinical Conversations

COURAGE Trial: Vibegron for BPH Patients with Persistent OAB Symptoms - David Staskin

David Staskin

David Staskin discusses the COURAGE trial, a phase three study evaluating the efficacy of Vibegron, a beta-3 adrenergic receptor agonist, in men with BPH and persistent OAB symptoms despite alpha-blocker treatment.

Comparison of ChatGPT and Traditional Patient Education Materials for Men’s Health - Yash Shah & Mihir Shah

Mihir Shah

Ruchika Talwar hosts Yash Shah and Mihir Shah, a urologist from Jefferson in Philadelphia.

Beyond the Abstracts

Low-Cord Orchidectomy for Testicular Cancer: What Would Be Different? - Beyond the Abstract

New Therapeutic Horizons for Advanced or Metastatic Penile Cancer - Beyond the Abstract

Conference Coverage

WCET 2024: The Prostate Microbiome is Associated with Prostate Size in BPH Patients

SUO 2023: Advances in Radiotherapy for Penile Cancer

SUO 2023: Robotic Inguinal Lymph Node Dissection

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Controversies in prostate cancer screening.

Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.

The Sensitivity and Specificity of Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Predicting Seminal Vesicle Invasion in Clinically Significant Prostate Cancer: A Mult

Systemic Treatments for Metastatic Prostate Cancer in 2024.

Intratumoral vitamin D signaling and lethal prostate cancer.

Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).

MYBL2 Drives Prostate Cancer Plasticity: Inhibiting its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.

Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer.

Outcomes after laser enucleation of the prostate with and without significant storage symptoms.

External Validation of Stockholm3 in a Retrospective German Clinical Cohort.

Impact of definitive radiotherapy on metabolic response measured with 68Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancer.

Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer.

Harnessing artificial intelligence for prostate cancer management.

Prevention of Device-Related Infections in Patients with Cancer: Current Practice and Future Horizons

A Phase 1b Dose Escalation Study of FOR46, a Novel Antibody-Drug Conjugate Targeting a Tumor-Specific Epitope of CD46, in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer

Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy.

Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients.

Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.

Targeting Androgen Receptor Alterations in Metastatic Prostate Cancer.

Centralized prostatectomy with intraoperative NeuroSAFE margin assessment improves surgical margin control.

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study.

Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy.

Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT.

18F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.

Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy.

From foes to friends: rethinking the role of lymph nodes in prostate cancer.

Early Identification and Management of Patients with Rash on Apalutamide.

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer.

Artera Announces Expansion of the ArteraAI Prostate Test to Inform Active Surveillance Decisions for Lower Risk Prostate Cancer Patients

Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting.

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies.

Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer.

Assessing the Heterogeneity of Response of [68Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate Cancer.

PSA Levels and Mortality in Prostate Cancer Patients.

Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer.

Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study.

Male Infertility

Sperm chromatin dispersion assay reliability and assisted reproductive technology outcomes: Systematic review and meta-analysis.

Inherited defects of piRNA biogenesis cause transposon de-repression, impaired spermatogenesis, and human male infertility.

Male Tract Microbiota and Male Infertility.

Bidirectional Mendelian randomization to explore the causal relationships between the gut microbiota and male reproductive diseases.

Idiopathic Secondary Azoospermia Occurrence in Men with Oligospermia over Time - Beyond the Abstract

Peyronie's Disease

Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria.

Prostatitis

Acute Bacterial Prostatitis Caused by Staphylococcus saprophyticus: A Case Report.

Erectile Dysfunction

Association between ankle-brachial blood pressure index and erectile dysfunction in US adults: a large population-based cross-sectional study.

Scoping review exploring advancements in topical agent therapies for erectile dysfunction.

DOES DIABETES HAVE A NEGATIVE IMPACT ON ERECTILE FUNCTION RECOVERY AFTER RADICAL PROSTATECTOMY?

The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease.

BPH - Benign Prostatic Enlargement

The early learning curve of the bipolar enucleation of the prostate: a multicenter cohort study.

Comparing embolic particles for prostatic artery embolization to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p/GPX4 signal pathway.

Does concordance between preoperatively measured prostate volume and enucleated weight predict outcomes in endoscopic enucleation of the prostate? Results from the REAP database.

Risks and side effects in the medical management of benign prostatic hyperplasia.

Penile & Urethral Cancers

The Development and Feasibility of a Novel Electronic Patient-Reported Outcome Measures (Eproms) Questionnaire in patients with penile cancer.

Local Therapy and Reconstruction in Penile Cancer: A Review.

Risk factors for distant metastasis and prognosis of the penile cancer with distant metastasis.

Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study - Beyond the Abstract

Testicular Cancer

Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell Tumors.

Discriminating Malignant from Benign Testicular Masses Using Multiparametric Magnetic Resonance Imaging-A Prospective Single-Center Study.

Contralateral Testicular Biopsy in Men with Testicular Cancer.

Opioid prescription following radical orchiectomy associated with new persistent opioid use.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2024 Digital Science Press, LLC